FDA issued a Warning Letter to Yicheng Goto Pharmaceuticals Co., Ltd on 7/26/2018 as a result of this inspection.
483 Yicheng Goto Pharmaceuticals Sep 2017

483 Yicheng Goto Pharmaceuticals Sep 2017

Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Yicheng Goto Pharmaceuticals - Xiangyang, China facility and issued inspectional observations (via FDA 483) on 14 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Sep 2017
  • Location: Xiangyang, China
  • FEI: 3004459466
Add To Cart